Table 2.
Primary indication | N (%) of patients | Survival rate—N (%) |
---|---|---|
MIS-C associated with COVID-19 infection | 8 (57.1) | 8 (100.0) |
HLH | 3 (21.4) | 1 (33.3) |
Systemic onset juvenile idiopathic arthritis flare | 2 (14.3) | 2 (100.0) |
Possible cytokine storm/hyperinflammatory state | 1 (7.1) | 0 |
Note. COVID-19 = coronavirus disease 19; HLH = hemophagocytic lymphohistiocytosis; MIS-C = multisystem inflammatory syndrome in children.